Evidence map›Paper›PMID 36121550›Full record

ArticleAIDS and behavior2023

HIV Risk Perception and Pre-Exposure Prophylaxis (PrEP) Awareness Among Transgender Women from Mexico.

Centli Guillen-Diaz-Barriga, Dulce Diaz-Sosa, Thiago S Torres, Kelika A Konda, Rebeca Robles-Garcia, Brenda Hoagland, Marcos Benedetti, Cristina Pimenta, Beatriz Grinsztejn, Carlos F Caceres and 2 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in AIDS and behavior, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Centli Guillen-Diaz-BarrigaNational Institute of Psychiatry Ramon de la Fuente Muñiz, Col. San Lorenzo Huipulco Alc. Tlalpan, 14370, Mexico City, Mexico.
Dulce Diaz-SosaNational Institute of Psychiatry Ramon de la Fuente Muñiz, Col. San Lorenzo Huipulco Alc. Tlalpan, 14370, Mexico City, Mexico.
Thiago S TorresInstituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Rio de Janeiro, Brazil.
Kelika A KondaUniversidad Peruana Cayetano Heredia, Lima, Peru.
Rebeca Robles-GarciaNational Institute of Psychiatry Ramon de la Fuente Muñiz, Col. San Lorenzo Huipulco Alc. Tlalpan, 14370, Mexico City, Mexico.
Brenda HoaglandInstituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Rio de Janeiro, Brazil.
Marcos BenedettiInstituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Rio de Janeiro, Brazil.
Cristina PimentaMinistry of Health, Brasilia, DF, Brazil.
Beatriz GrinsztejnInstituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Rio de Janeiro, Brazil.
Carlos F CaceresUniversidad Peruana Cayetano Heredia, Lima, Peru.
Valdilea G VelosoInstituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Rio de Janeiro, Brazil.
Hamid Vega-RamirezNational Institute of Psychiatry Ramon de la Fuente Muñiz, Col. San Lorenzo Huipulco Alc. Tlalpan, 14370, Mexico City, Mexico. hamid.vega@gmail.com.
Fundação Oswaldo Cruz · BRInstituto Nacional de Psiquiatría · MXUniversidad Peruana Cayetano Heredia · PEMinistério da Saúde · BR

Funding

The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)U01AI069476 · NIAID · FUNDACAO OSWALDO CRUZ · PI GRINSZTEJN, BEATRIZ · 2008 to 2011
$14.0M
Conselho Nacional de Desenvolvimento Científico e Tecnológico 4/2021Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro E33/2021NIAID NIH HHS U01 AI069476Unitaid 2017-15FIOTECPrEP
6 · The paper itself

Abstract

This study aimed to identify factors associated with HIV risk perception among Mexican transgender women (TGW). This cross-sectional survey was conducted online and at a public HIV clinic in Mexico City. Participants were ≥ 18 years old, self-identified as TGW, and reported not living with HIV. They answered questions on sexual behavior, HIV risk perception, and pre-exposure prophylaxis (PrEP) awareness. We performed a multivariate logistic regression to accomplish the study's objective. One hundred ninety-one TGW completed the survey. High HIV risk perception was associated with > 5 sexual partners, condomless receptive anal sex, sex with a male partner(s) of unknown HIV status, and PrEP awareness. Although most TGW reported low HIV risk perception, over half had risk sexual behavior, reflecting inaccurate risk assessment. Future interventions to improve accurate risk perception among TGW should promote HIV transmission and prevention knowledge and increase PrEP awareness and uptake.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisTransgender PersonsAdolescentCross-Sectional StudiesFemaleHomosexuality, MaleHumansMaleMexicoPerceptionAnti-HIV AgentsHIV preventionHIV risk perceptionPrEP awarenessrisk sexual behaviortransgender women

Identifiers

PMID36121550
OpenAlexW4296331280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.